RLAY NASDAQ
Relay Therapeutics, Inc.
1W: +6.9%
1M: -17.3%
3M: +57.0%
YTD: +67.0%
1Y: +347.9%
3Y: +36.7%
5Y: -53.2%
$13.53
-0.13 (-0.95%)
Weekly Expected Move ±8.8%
$10
$11
$12
$13
$14
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$11M
Revenue
+39.0% YoY
$-273M
Net Income
+18.2% YoY
$-213M
Free Cash Flow
+21.7% YoY
83.2%
Gross Margin
-2619.7%
Op. Margin
-2443.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-40.6%
ROA-36.5%
ROIC-520.5%
Valuation
P/E-8.9
P/B3.8
EV/EBITDA-4.4
Leverage
Debt/Equity0.06
Current Ratio22.61
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z14.82
Beneish M-3.82